Fig. 1From: A metabolome-wide case-control study of african american breast cancer patientsIdentification of metabolic features associated with breast cancer. The positive fold change (log2) indicates higher feature intensity among cases. (1) Scenario 1, all breast cancer cases (n = 125); (2) Scenario 2, cases without any treatments (chemotherapy, radiotherapy, and surgery) before serum collection (n = 68); (3) Scenario 3, cases with any treatments (chemotherapy, radiotherapy, and surgery) before serum collection (n = 57); (4) Scenario 4, cases with negative lymph nodes (n = 72); (5) Scenario 5, cases with positive lymph nodes (n = 52); (6) Scenario 6, cases with stage I cancer (n = 49); (7) Scenario 7, cases with stage II/III cancer (n = 76)Back to article page